Amyaouch Bradaïa

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Florent G. Revel, Jean‐Luc Moreau, Raul R. Gainetdinov et al. · Proceedings of the National Academy of Sciences · 2011 · 362 citations · Full text

Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity

Lothar Lindemann, Claas A. Meyer, Karine Jeanneau et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 347 citations

Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease

Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen et al. · PLoS ONE · 2012 · 323 citations · Full text

Genetics, Disease Gene Identification, Mri Brain Volumetry +16

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

F. Revel, J‐L Moreau, Bruno Pouzet et al. · Molecular Psychiatry · 2012 · 285 citations

Psychoactive Drug, Psychiatry, Psychotic Disorder +13

The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

Amyaouch Bradaïa, Gerhard Trube, Henri Stalder et al. · Proceedings of the National Academy of Sciences · 2009 · 247 citations · Full text

Neurotransmitter, Neurotransmission, Selective Taar1 Antagonist +22